Lysis-deficient bacteriophage therapy decreases endotoxin and inflammatory mediator release and improves survival in a murine peritonitis model
- 30 June 2005
- journal article
- research article
- Published by Elsevier
- Vol. 137 (6) , 639-646
- https://doi.org/10.1016/j.surg.2005.02.012
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faeciumInfection and Immunity, 2002
- Functional analysis of the phage T4 holin in a λ contextMolecular Genetics and Genomics, 2001
- Bacteriophage TherapyAntimicrobial Agents and Chemotherapy, 2001
- Phage therapy—advantages over antibiotics?The Lancet, 2000
- Holins: The Protein Clocks of Bacteriophage InfectionsAnnual Review of Microbiology, 2000
- Microbiologic Findings and Correlations with Serum Tumor Necrosis Factor–α in Patients with Severe Sepsis and Septic ShockThe Journal of Infectious Diseases, 1999
- ANTIBIOTIC TREATMENT INFLUENCES OUTCOME IN MURINE SEPSISShock, 1998
- The release of endotoxin from antibiotic-treated Escherichia coli and the production of tumour necrosis factor by human monocytesJournal of Antimicrobial Chemotherapy, 1993
- Effects of Different Types and Combinations of Antimicrobial Agents on Endotoxin Release from Gram-negative Bacteria: An In-Vitro and In-Vivo StudyScandinavian Journal of Infectious Diseases, 1991
- Release of outer membrane fragments from normally growing Escherichia coliBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976